These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 24720563)

  • 1. Safe clinical use of carbon nanotubes as innovative biomaterials.
    Saito N; Haniu H; Usui Y; Aoki K; Hara K; Takanashi S; Shimizu M; Narita N; Okamoto M; Kobayashi S; Nomura H; Kato H; Nishimura N; Taruta S; Endo M
    Chem Rev; 2014 Jun; 114(11):6040-79. PubMed ID: 24720563
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbon nanotubes: biomaterial applications.
    Saito N; Usui Y; Aoki K; Narita N; Shimizu M; Hara K; Ogiwara N; Nakamura K; Ishigaki N; Kato H; Taruta S; Endo M
    Chem Soc Rev; 2009 Jul; 38(7):1897-903. PubMed ID: 19551170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology in medicine: nanofilm biomaterials.
    Van Tassel PR
    Yale J Biol Med; 2013 Dec; 86(4):527-36. PubMed ID: 24348217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of multiwalled carbon nanotubes with end defects critically depends on their functionalization density.
    Jain S; Thakare VS; Das M; Godugu C; Jain AK; Mathur R; Chuttani K; Mishra AK
    Chem Res Toxicol; 2011 Nov; 24(11):2028-39. PubMed ID: 21978239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon nanotube uptake and toxicity in the brain.
    Zhang L; Alizadeh D; Badie B
    Methods Mol Biol; 2010; 625():55-65. PubMed ID: 20422381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The biocompatibility of carbon nanotubes].
    Sun L; Zhang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):742-6. PubMed ID: 18693469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological properties of carbon nanotubes.
    Wei W; Sethuraman A; Jin C; Monteiro-Riviere NA; Narayan RJ
    J Nanosci Nanotechnol; 2007; 7(4-5):1284-97. PubMed ID: 17450891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of biocompatible dispersants for carbon nanotube toxicity tests.
    Kim JS; Song KS; Lee JH; Yu IJ
    Arch Toxicol; 2011 Dec; 85(12):1499-508. PubMed ID: 21656221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity studies of carbon nanotubes.
    Kolosnjaj J; Szwarc H; Moussa F
    Adv Exp Med Biol; 2007; 620():181-204. PubMed ID: 18217344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vivo biocompatibility study of single- and multi-wall carbon nanotubes.
    Fraczek A; Menaszek E; Paluszkiewicz C; Blazewicz M
    Acta Biomater; 2008 Nov; 4(6):1593-602. PubMed ID: 18585111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispersion and solubilization of carbon nanotubes.
    Fu K; Sun YP
    J Nanosci Nanotechnol; 2003 Oct; 3(5):351-64. PubMed ID: 14733142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research and development of biomedical application of carbon nanotubes and related composites].
    Guo X; Xu H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):438-41. PubMed ID: 16706384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon nanotube-based biomaterials for orthopaedic applications.
    Aoki K; Ogihara N; Tanaka M; Haniu H; Saito N
    J Mater Chem B; 2020 Oct; 8(40):9227-9238. PubMed ID: 32935730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalised carbon nanotubes: From intracellular uptake and cell-related toxicity to systemic brain delivery.
    Costa PM; Bourgognon M; Wang JT; Al-Jamal KT
    J Control Release; 2016 Nov; 241():200-219. PubMed ID: 27693751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo biocompatibility testing of functionalized carbon nanotubes.
    Ciofani G; Raffa V; Vittorio O; Cuschieri A; Pizzorusso T; Costa M; Bardi G
    Methods Mol Biol; 2010; 625():67-83. PubMed ID: 20422382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon nanotubes for biomedical applications.
    Sinha N; Yeow JT
    IEEE Trans Nanobioscience; 2005 Jun; 4(2):180-95. PubMed ID: 16117026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice.
    Takanashi S; Hara K; Aoki K; Usui Y; Shimizu M; Haniu H; Ogihara N; Ishigaki N; Nakamura K; Okamoto M; Kobayashi S; Kato H; Sano K; Nishimura N; Tsutsumi H; Machida K; Saito N
    Sci Rep; 2012; 2():498. PubMed ID: 22787556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon nanotubes: engineering biomedical applications.
    Gomez-Gualdrón DA; Burgos JC; Yu J; Balbuena PB
    Prog Mol Biol Transl Sci; 2011; 104():175-245. PubMed ID: 22093220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of grafted collagen-multiwalled carbon nanotubes composites.
    Cao Y; Zhou YM; Shan Y; Ju HX; Xue XJ
    J Nanosci Nanotechnol; 2007 Feb; 7(2):447-51. PubMed ID: 17450777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood compatible carbon nanotubes--nano-based neoproteoglycans.
    Murugesan S; Park TJ; Yang H; Mousa S; Linhardt RJ
    Langmuir; 2006 Apr; 22(8):3461-3. PubMed ID: 16584210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.